We are seeking partnerships with biopharmaceutical companies and investors who share our vision for improved cancer treatment. Our proprietary delivery technology is designed to deliver chemotherapy, nanobody-drug conjugates, and other therapeutic candidates directly to tumors with greater efficiency and fewer side effects while also reducing development costs and timelines. Join us in developing more effective and accessible cancer therapies. Together, we can make a significant difference for patients worldwide.